M&A Deal Summary

Cyprotex Acquires Apredica

On August 6, 2010, Cyprotex acquired life science company Apredica for 3M GBP

Acquisition Highlights
  • This is Cyprotex’s 1st transaction in the Life Science sector.
  • This is Cyprotex’s largest (disclosed) transaction.
  • This is Cyprotex’s 1st transaction in the United States.
  • This is Cyprotex’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2010-08-06
Target Apredica
Sector Life Science
Buyer(s) Cyprotex
Deal Type Add-on Acquisition
Deal Value 3M GBP

Target

Apredica

Watertown, Massachusetts, United States
Apredica, LLC is a US-based CRO specialising in preclinical ADME and Toxicology assessment.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cyprotex

Macclesfield, United Kingdom
Category Company
Founded 1999
Sector Life Science
Employees116
Revenue 16M GBP (2016)
DESCRIPTION

Cyprotex PLC is a specialist ADME-Tox Contract Research Organisation, serves the Pharmaceutical and Biotech, Cosmetics/Personal Care and Chemicals Industries as well as academia and not-for-profit organisations.

DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 2
State (Massachusetts) 1 of 1
Country (United States) 1 of 2
Year (2010) 1 of 1
Size (of disclosed) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-02 CeeTox

Kalamazoo, Michigan, United States

CeeTox, Inc. is a Contract Research Organisation specialising in the provision of in vitro toxicological assays and screening data, principally to the Cosmetic and Personal Care Industries.

Buy -
Mergr

Product

Company

Legal